Patents Assigned to Jazz Pharmaceuticals International III Limited
  • Treatment of cataplexy
    Patent number: 10259780
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: April 16, 2019
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Formulations of (R)-2-amino-3-phenylpropyl carbamate
    Patent number: 10195151
    Abstract: The present invention relates to immediate release formulations of (R)-2-amino-3-phenylpropyl carbamate and methods of using the same to treat disorders.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: February 5, 2019
    Assignee: Jazz Pharmaceuticals International III Limited
    Inventors: Clark Patrick Allphin, Edwin Gerard Walsh
  • Treatment for obesity
    Patent number: 10105341
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: October 23, 2018
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Treatment for obesity
    Patent number: 9649291
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: December 1, 2015
    Date of Patent: May 16, 2017
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Treatment of cataplexy
    Patent number: 9585863
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: March 7, 2017
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Treatment of cataplexy
    Patent number: 9359290
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: June 7, 2016
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Treatment for obesity
    Patent number: 9226910
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: January 5, 2016
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts